InMed Pharmaceuticals INM Insider Ownership

NASDAQ INM

$15.56 +2.56 (+19.65%)

At close: Nov 6, 2026 · 4:00 PM EST

Insider Holdings by Owner

177.94K Shares

Capital Management, Llc Adar195.66K53.8%

Opportunity, Llc Vivo81.81K46.0%

Eric A Adams2200.1%

Andrew Hull1910.1%

Shane Aaron Johnson610.0%

Other insiders (1)20.0%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

3.12%

▲+0.121% pp QoQ

Shares Held by Insiders

171.49K

filed for Sep 2026

▲+7.03% QoQ

Shares Outstanding

5.49Mn

5,493,735 shares

Direct Holdings

472

Indirect: 171.02K

Net Open-Market Trades

+118.60K

net bought · $160.70K in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 5, 2026

Over the past 12 months, InMed Pharmaceuticals insiders bought $1.36 million of stock on the open market and made no open-market sales.

By number of insiders, InMed Pharmaceuticals saw 2 insiders buy on the open market over the past 12 months and none sell.
Among InMed Pharmaceuticals' insiders, the largest open-market purchases in the past 12 months were by Adar1 Capital Management, LLC (10% owner), totaling $926,902, most recently on October 23, 2026.
Per Business Quant data, InMed Pharmaceuticals insiders hold 177.94K shares in total based on their latest Form 4 filings, up 11.06% from 160.22K shares (split-adjusted) at the end of Q2 2026.
By type of ownership, INM insiders hold 0.27% of their shares directly (472 shares) and 99.73% indirectly (177.47K shares).
The insider holdings in InMed Pharmaceuticals belong to 5 insiders who have reported on Form 4 within the past two years.
INM's largest insider holders by reported holdings are Adar1 Capital Management, LLC (10% owner, 95.66K shares), Vivo Opportunity, LLC (10% owner, 81.81K shares) and Eric A. Adams (President & CEO, 220 shares).
The holding of Adar1 Capital Management, LLC makes up 53.76% of all shares held by InMed Pharmaceuticals insiders.
Institutions held 5.05% of InMed Pharmaceuticals' outstanding shares in their Q2 2026 13F filings, insiders about 3.24% based on their latest Form 4 filings, and other investors, including the public, the remaining 91.71%.
Over the past 12 months, 11 insiders reported transactions in InMed Pharmaceuticals stock in 24 Form 4 filings.
These insider figures for InMed Pharmaceuticals are based on Form 4 filings through October 23, 2026.

Form 4 Holdings

Insiders Holding INM

Insiders 6

Shares held 177.94K

Of outstanding 3.24%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Capital Management, Llc Adar1	TenPercentOwner	0	95,658	95,658	53.8%	23 Oct, 2026
2	Opportunity, Llc Vivo	TenPercentOwner	0	81,808	81,808	46.0%	16 Jul, 2026
3	Eric A Adams	President Ceo	220	0	220	0.1%	21 Feb, 2024
4	Andrew Hull	Director	191	0	191	0.1%	22 Feb, 2024
5	Shane Aaron Johnson	Svp, Gm Of Baymedica Llc	61	0	61	0.0%	06 Jan, 2022
6	Bruce Colwill	Cfo	2	0	2	0.0%	24 Jan, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

165 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
23 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	4	$1.32	$5	956,584	Indirect
16 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	1	$1.32	$1	955,494	Indirect
19 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	1,086	$1.32	$1.43K	956,580	Indirect
13 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	564	$1.33	$750	946,488	Indirect
14 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	8,021	$1.33	$10.67K	954,509	Indirect
15 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	984	$1.32	$1.30K	955,493	Indirect
06 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	5,601	$1.33	$7.44K	940,622	Indirect
07 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	3,046	$1.33	$4.05K	943,668	Indirect
08 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	2,256	$1.33	$3.00K	945,924	Indirect
01 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	16,431	$1.33	$21.85K	908,532	Indirect
02 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	8,307	$1.33	$11.05K	916,839	Indirect
05 Oct, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	18,182	$1.33	$24.18K	935,021	Indirect
14 Sep, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	28,505	$1.29	$36.88K	829,505	Indirect
15 Sep, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	54,256	$1.30	$70.45K	883,761	Indirect
16 Sep, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	8,340	$1.29	$10.75K	892,101	Indirect
15 Jul, 2026	Capital Management, Llc Adar1	TenPercentOwner	Acquired P	1,000	$1.56	$1.56K	801,000	Indirect
14 Jul, 2026	Opportunity, Llc Vivo	TenPercentOwner	Acquired P	4,882	$1.55	$7.57K	729,277	Indirect
14 Jul, 2026	Opportunity, Llc Vivo	TenPercentOwner	Acquired P	493	$1.55	$764	73,628	Indirect
15 Jul, 2026	Opportunity, Llc Vivo	TenPercentOwner	Acquired P	13,761	$1.55	$21.33K	743,038	Indirect
15 Jul, 2026	Opportunity, Llc Vivo	TenPercentOwner	Acquired P	1,389	$1.55	$2.15K	75,017	Indirect

Showing 1 to 20 of 165 transactions